Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells

Journal of Biological Chemistry

Volumn 288, Issue 18, 2013, Pages 12722-12732

  Barcus, Craig E ^a,c   Keely, Patricia J ^b,c,d   Eliceiri, Kevin W ^c,d   Schuler, Linda A ^a,c,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER CELLS; COLLAGEN SCAFFOLDS; EXTRACELLULAR MATRICES; FOCAL ADHESION KINASE; FUNCTIONAL RELATIONSHIP; MITOGEN ACTIVATED PROTEIN KINASE; PROLACTIN RECEPTORS; SPATIAL RELATIONSHIPS;

AMINO ACIDS; CELLS; DISEASES; ENZYME INHIBITION; PHYSIOLOGY; SCAFFOLDS; STIFFNESS; STIFFNESS MATRIX; TUMORS;

COLLAGEN;

COLLAGEN; FOCAL ADHESION KINASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; PROLACTIN; PROLACTIN RECEPTOR; TYROSINE;

ANTIBODY SPECIFICITY; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RIGIDITY; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION;

BREAST CANCER; COLLAGEN; DENSITY; DESMOPLASIA; EXTRACELLULAR MATRIX; FOCAL ADHESION KINASE; PROLACTIN;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; FEMALE; FOCAL ADHESION KINASE 1; GRB2 ADAPTOR PROTEIN; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM PROTEINS; PHOSPHORYLATION; PROLACTIN; STAT5 TRANSCRIPTION FACTOR;

EID: 84877115047     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.447631     Document Type: Article

References (79)

1. Freeman, M. E., Kanyicska, B., Lerant, A., and Nagy, G. (2000) Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 80, 1523-1631
2. Oakes, S. R., Rogers, R. L., Naylor, M. J., and Ormandy, C. J. (2008) Prolactin regulation of mammary gland development. J. Mammary Gland Biol. Neoplasia 13, 13-28
3. Tworoger, S. S., and Hankinson, S. E. (2008) Prolactin and breast cancer etiology: an epidemiologic perspective. J. Mammary Gland Biol. Neoplasia 13, 41-53
4. Fernandez, I., Touraine, P., and Goffin, V. (2010) Prolactin and human tumourogenesis. J. Neuroendocrinol. 22, 771-777
5. Clevenger, C. V., Furth, P. A., Hankinson, S. E., and Schuler, L. A. (2003) The role of prolactin in mammary carcinoma. Endocr. Rev. 24, 1-27 (Pubitemid 36223277)
6. Jacobson, E. M., Hugo, E. R., Borcherding, D. C., and Ben-Jonathan, N. (2011) Prolactin in breast and prostate cancer: molecular and genetic perspectives. Discov. Med. 11, 315-324
7. Bole-Feysot, C., Goffin, V., Edery, M., Binart, N., and Kelly, P. A. (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev. 19, 225-268 (Pubitemid 29117815)
8. Hennighausen, L., Robinson, G. W., Wagner, K. U., and Liu, X. (1997) Developing a mammary gland is a stat affair. J. Mammary Gland Biol. Neoplasia 2, 365-372 (Pubitemid 127718720)
9. Wagner, K. U., Krempler, A., Triplett, A. A., Qi, Y., George, N. M., Zhu, J., and Rui, H. (2004) Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol. Cell. Biol. 24, 5510-5520 (Pubitemid 38738182)
10. Peck, A. R., Witkiewicz, A. K., Liu, C., Stringer, G. A., Klimowicz, A. C., Pequignot, E., Freydin, B., Tran, T. H., Yang, N., Rosenberg, A. L., Hooke, J. A., Kovatich, A. J., Nevalainen, M. T., Shriver, C. D., Hyslop, T., Sauter, G., Rimm, D. L., Magliocco, A. M., and Rui, H. (2011) Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J. Clin. Oncol. 29, 2448-2458
11. Cotarla, I., Ren, S., Zhang, Y., Gehan, E., Singh, B., and Furth, P. A. (2004) Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int. J. Cancer 108, 665-671 (Pubitemid 38076397)
12. Yamashita, H., Nishio, M., Ando, Y., Zhang, Z., Hamaguchi, M., Mita, K., Kobayashi, S., Fujii, Y., and Iwase, H. (2006) Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer. Endocr. Relat. Cancer 13, 885-893 (Pubitemid 44763264)
13. Arendt, L. M., Rugowski, D. E., Grafwallner-Huseth, T. A., Garcia-Barchino, M. J., Rui, H., and Schuler, L. A. (2011) Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer. Breast Cancer Res. 13, R11
14. Arendt, L. M., Evans, L. C., Rugowski, D. E., Garcia-Barchino, M. J., Rui, H., and Schuler, L. A. (2009) Ovarian hormones are not required for PRL-FIGURE induced mammary tumorigenesis, but estrogen enhances neoplastic processes. J. Endocrinol. 203, 99-110
15. Arendt, L. M., Rose-Hellekant, T. A., Sandgren, E. P., and Schuler, L. A. (2006) Prolactin potentiates transforming growth factor α induction of mammary neoplasia in transgenic mice. Am. J. Pathol. 168, 1365-1374
16. Carver, K. C., and Schuler, L. A. (2008) Prolactin does not require insulin-like growth factor intermediates but synergizes with insulin-like growth factor I in human breast cancer cells. Mol. Cancer Res. 6, 634-643 (Pubitemid 351521845)
17. Gutzman, J. H., Rugowski, D. E., Nikolai, S. E., and Schuler, L. A. (2007) Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context. Oncogene 26, 6341-6348 (Pubitemid 47462105)
18. Sato, H., and Seiki, M. (1993) Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395-405 (Pubitemid 23073756)
19. Sultan, A. S., Xie, J., LeBaron, M. J., Ealley, E. L., Nevalainen, M. T., and Rui, H. (2005) Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 24, 746-760 (Pubitemid 40216084)
20. Boyd, N. F., Lockwood, G. A., Byng, J. W., Tritchler, D. L., and Yaffe, M. J. (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 7, 1133-1144 (Pubitemid 29001671)
21. McCormack, V. A., and dos Santos Silva, I. (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15, 1159-1169
22. Vachon, C. M., van Gils, C. H., Sellers, T. A., Ghosh, K., Pruthi, S., Brandt, K. R., and Pankratz, V. S. (2007) Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res. 9, 217
23. Keely, P. J., Wu, J. E., and Santoro, S. A. (1995) The spatial and temporal expression of the α2β1 integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary morphogenesis. Differentiation 59, 1-13
24. Li, T., Sun, L., Miller, N., Nicklee, T., Woo, J., Hulse-Smith, L., Tsao, M.-S., Khokha, R., Martin, L., and Boyd, N. (2005) The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol. Biomarkers Prev. 14, 343-349 (Pubitemid 40270095)
25. Walker, R. A. (2001) The complexities of breast cancer desmoplasia. Breast Cancer Res. 3, 143-145
26. Keely, P. (2011) Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. J. Mammary Gland Biol. Neoplasia 16, 205-219
27. Butcher, D. T., Alliston, T., and Weaver, V. M. (2009) A tense situation: forcing tumour progression. Nat. Rev. Cancer 9, 108-122
28. Provenzano, P. P., Inman, D. R., Eliceiri, K. W., and Keely, P. J. (2009) Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 28, 4326-4343
29. Acosta, J. J., Muñoz, R. M., González, L., Subtil-Rodríguez, A., Dominguez-Caceres, M. A., García- Martínez, J. M., Calcabrini, A., Lazaro-Trueba, I., and Martín-Pérez, J. (2003) Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Mol. Endocrinol. 17, 2268-2282 (Pubitemid 37352537)
30. Gutzman, J. H., Rugowski, D. E., Schroeder, M. D., Watters, J. J., and Schuler, L. A. (2004) Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells. Mol. Endocrinol. 18, 3064-3075 (Pubitemid 39577926)
31. Piazza, T. M., Lu, J. C., Carver, K. C., and Schuler, L. A. (2009) Src family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells. Mol. Endocrinol. 23, 202-212
32. Canbay, E., Norman, M., Kilic, E., Goffin, V., and Zachary, I. (1997) Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells. Biochem. J. 324, 231-236 (Pubitemid 27229387)
33. Schroeder, M. D., Symowicz, J., and Schuler, L. A. (2002) PRL modulates cell cycle regulators in mammary tumor epithelial cells. Mol. Endocrinol. 16, 45-57 (Pubitemid 34044497)
34. Wozniak, M. A., and Keely, P. J. (2005) Use of three-dimensional collagen gels to study mechanotransduction in T47D breast epithelial cells. Biol. Proced. Online 7, 144-161 (Pubitemid 41574308)
35. Provenzano, P. P., Inman, D. R., Eliceiri, K. W., Beggs, H. E., and Keely, P. J. (2008) Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Am. J. Pathol. 173, 1551-1565
36. Provenzano, P. P., Inman, D. R., Eliceiri, K. W., Knittel, J. G., Yan, L., Rueden, C. T., White, J. G., and Keely, P. J. (2008) Collagen density promotes mammary tumor initiation and progression. BMC Med. 6, 11
37. Kleiner, D. E., and Stetler-Stevenson, W. G. (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218, 325-329 (Pubitemid 24141631)
38. Costes, S. V., Daelemans, D., Cho, E. H., Dobbin, Z., Pavlakis, G., and Lockett, S. (2004) Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 86, 3993-4003 (Pubitemid 38780275)
39. Denk, W., Strickler, J. H., and Webb, W. W. (1990) Two-photon laser scanning fluorescence microscopy. Science 248, 73-76
40. Mohler, W., Millard, A. C., and Campagnola, P. J. (2003) Second harmonic generation imaging of endogenous structural proteins. Methods 29, 97-109 (Pubitemid 36259916)
41. Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G., and Keely, P. J. (2006) Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 4, 38
42. Lahlou, H., and Muller, W. (2011) β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer. Breast Cancer Res. 13, 229
43. Streuli, C. H. (2009) Integrins and cell-fate determination. J. Cell Sci. 122, 171-177
44. Mould, A. P., Akiyama, S. K., and Humphries, M. J. (1996) The inhibitory anti-β1 integrin monoclonal antibody 13 recognizes an epitope that is attenuated by ligand occupancy. Evidence for allosteric inhibition of integrin function. J. Biol. Chem. 271, 20365-20374 (Pubitemid 26281804)
45. Akhtar, N., Marlow, R., Lambert, E., Schatzmann, F., Lowe, E. T., Cheung, J., Katz, E., Li, W., Wu, C., Dedhar, S., Naylor, M. J., and Streuli, C. H. (2009) Molecular dissection of integrin signalling proteins in the control of mammary epithelial development and differentiation. Development 136, 1019-1027
46. Akhtar, N., and Streuli, C. H. (2006) Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia. J. Cell Biol. 173, 781-793 (Pubitemid 46165585)
47. Köhrmann, A., Kammerer, U., Kapp, M., Dietl, J., and Anacker, J. (2009) Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature. BMC Cancer 9, 188
48. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
49. Conklin, M. W., Eickhoff, J. C., Riching, K. M., Pehlke, C. A., Eliceiri, K. W., Provenzano, P. P., Friedl, A., and Keely, P. J. (2011) Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am. J. Pathol. 178, 1221-1232
50. Ingman, W. V., Wyckoff, J., Gouon-Evans, V., Condeelis, J., and Pollard, J. W. (2006) Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev. Dyn. 235, 3222-3229 (Pubitemid 44888188)
51. Brunton, V. G., Avizienyte, E., Fincham, V. J., Serrels, B., Metcalf, C. A., 3rd, Sawyer, T. K., and Frame, M. C. (2005) Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior. Cancer Res. 65, 1335-1342 (Pubitemid 40270160)
52. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R., and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315
53. Schlaepfer, D. D., Hanks, S. K., Hunter, T., and van der Geer, P. (1994) Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372, 786-791
54. Boateng, L. R., and Huttenlocher, A. (2012) Spatiotemporal regulation of Src and its substrates at invadosomes. Eur. J. Cell Biol. 91, 878-888
55. Tomar, A., and Schlaepfer, D. (2009) Focal adhesion kinase: switching between GAP's and GEF's in the regulation of cell motility. Curr. Opin. Cell Biol. 21, 676-683
56. Wehrle-Haller, B. (2012) Assembly and disassembly of cell matrix adhesions. Curr. Opin. Cell Biol. 24, 569-581
57. Wozniak, M. A., Desai, R., Solski, P. A., Der, C. J., and Keely, P. J. (2003) ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J. Cell Biol. 163, 583-595 (Pubitemid 37429871)
58. Schaller, M. D., Hildebrand, J. D., Shannon, J. D., Fox, J. W., Vines, R. R., and Parsons, J. T. (1994) Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 14, 1680-1688
59. Schaller, M. D., Otey, C. A., Hildebrand, J. D., and Parsons, J. T. (1995) Focal adhesion kinase and paxillin bind to peptides mimicking β integrin cytoplasmic domains. J. Cell Biol. 130, 1181-1187
60. Chan, K. T., Cortesio, C. L., and Huttenlocher, A. (2009) FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J. Cell Biol. 185, 357-370
61. Gialeli, C., Theocharis, A. D., and Karamanos, N. K. (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278, 16-27
62. Deryugina, E. I., and Quigley, J. P. (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25, 9-34 (Pubitemid 43723979)
63. Singh, J., Murata, K., Itahana, Y., and Desprez, P.-Y. (2002) Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene 21, 1812-1822 (Pubitemid 34259183)
64. Wu, Y., Deng, J., Rychahou, P. G., Qiu, S., Evers, B. M., and Zhou, B. P. (2009) Stabilization of snail by NF-κB is required for inflammation-induced cell migration and invasion. Cancer Cell 15, 416-428
65. Katz, E., and Streuli, C. H. (2007) The extracellular matrix as an adhesion checkpoint for mammary epithelial function. Int. J. Biochem. Cell Biol. 39, 715-726 (Pubitemid 46366801)
66. Kass, L., Erler, J. T., Dembo, M., and Weaver, V. M. (2007) Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int. J. Biochem. Cell Biol. 39, 1987-1994 (Pubitemid 47369248)
67. Chan, K. T., Bennin, D. A., and Huttenlocher, A. (2010) Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK). J. Biol. Chem. 285, 11418-11426
68. Luo, M., Fan, H., Nagy, T., Wei, H., Wang, C., Liu, S., Wicha, M. S., and Guan, J.-L. (2009) Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res. 69, 466-474
69. Lahlou, H., Sanguin-Gendreau, V., Zuo, D., Cardiff, R. D., McLean, G. W., Frame, M. C., and Muller, W. J. (2007) Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc. Natl. Acad. Sci. U.S.A. 104, 20302-20307
70. Moro, L., Venturino, M., Bozzo, C., Silengo, L., Altruda, F., Beguinot, L., Tarone, G., and Defilippi, P. (1998) Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J. 17, 6622-6632 (Pubitemid 28521796)
71. Plopper, G. E., McNamee, H. P., Dike, L. E., Bojanowski, K., and Ingber, D. E. (1995) Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell 6, 1349-1365
72. Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., Hammer, D. A., and Weaver, V. M. (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254 (Pubitemid 41317594)
73. Gass, S., Harris, J., Ormandy, C., and Brisken, C. (2003) Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function. J. Mammary Gland Biol. Neoplasia 8, 269-285 (Pubitemid 39137511)
74. Greendale, G. A., Huang, M.-H., Ursin, G., Ingles, S., Stanczyk, F., Crandall, C., Laughlin, G. A., Barrett-Connor, E., and Karlamangla, A. (2007) Serum prolactin levels are positively associated with mammographic density in postmenopausal women. Breast Cancer Res. Treat. 105, 337-346 (Pubitemid 47596443)
75. Bremnes, Y., Ursin, G., Bjurstam, N., Rinaldi, S., Kaaks, R., and Gram, I. T. (2007) Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Int. J. Cancer 121, 2506-2511 (Pubitemid 350022421)
76. Xu, C., Langenheim, J. F., and Chen, W. Y. (2012) Stromal-epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer. Breast Cancer Res. Treat. 134, 157-169
77. Gioni, V., Karampinas, T., Voutsinas, G., Roussidis, A. E., Papadopoulos, S., Karamanos, N. K., and Kletsas, D. (2008) Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts. Mol. Cancer Res. 6, 706-714
78. Du, J.-Y., Chen, M.-C., Hsu, T.-C., Wang, J.-H., Brackenbury, L., Lin, T.-H., Wu, Y.-Y., Yang, Z., Streuli, C. H., and Lee, Y.-J. (2012) The RhoA-Rok-myosin II pathway is involved in extracellular matrix-mediated regulation of prolactin signaling in mammary epithelial cells. J. Cell. Physiol. 227, 1553-1560
79. Plotnikov, A., Li, Y., Tran, T. H., Tang, W., Palazzo, J. P., Rui, H., and Fuchs, S. Y. (2008) Oncogene-mediated inhibition of glycogen synthase kinase 3β impairs degradation of prolactin receptor. Cancer Res. 68, 1354-1361 (Pubitemid 351346842)